Add like
Add dislike
Add to saved papers

Structural characterization of two solvates of a luminescent copper(II) bis-(pyridine)-substituted benzimidazole complex.

Copper(II) complexes of benzimidazole are known to exhibit biological activity that makes them of inter-est for chemotherapeutic and other pharmaceutical uses. The complex bis-(acetato-κ O ){5,6-dimethyl-2-(pyridin-2-yl)-1-[(pyridin-2-yl)meth-yl]-1 H -benzimidazole-κ2 N 2 , N 3 }copper(II), has been prepared. The absorption spectrum has features attributed to intra-ligand and ligand-field transitions and the complex exhibits ligand-centered room-temperature luminescence in solution. The aceto-nitrile monosolvate, [Cu(C2 H3 O2 )2 (C20 H18 N4 )]·C2 H3 N ( 1 ), and the ethanol hemisolvate, [Cu(C2 H3 O2 )2 (C20 H18 N4 )]·0.5C2 H6 O ( 2 ), have been structurally characterized. Compound 2 has two copper(II) complexes in the asymmetric unit. In both 1 and 2 , distorted square-planar N2 O2 coordination geometries are observed and the Cu-N(Im) bond distance is slightly shorter than the Cu-N(py) bond distance. Inter-molecular π-π inter-actions are found in 1 and 2 . A weak C-H⋯π inter-action is observed in 1 .

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app